PAUL CORN to Interferon-alpha
This is a "connection" page, showing publications PAUL CORN has written about Interferon-alpha.
Connection Strength
0.066
-
Upfront, randomized, phase 2 trial of sorafenib versus sorafenib and low-dose interferon alfa in patients with advanced renal cell carcinoma: clinical and biomarker analysis. Cancer. 2010 Jan 01; 116(1):57-65.
Score: 0.066